Replay available

Bristol-Myers Squibb Company (BMY) Q2 2026 Earnings Call

Bristol-Myers Squibb Company (NYSE: BMY) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Thu, July 30, 2026 at 8:15 AMendedReplay
Bristol-Myers Squibb Company (BMY) Q2 2026 Earnings Call

Hosted by

Featured presenters

Louisa Hector

Barenburg Analyst

Cristian Massacesi

Chief Medical Officer and Head of Global Drug Development

Jason Gerberry

Bank of America Analyst

Asad Haider

Goldman Sachs Analyst

Seamus Fernandez

Guggenheim Securities Analyst

Evan Ziegerman

BMO Capital Markets Analyst

Adam Lenkowski

Chief Commercialization Officer

Jeff Meacham

Citibank Analyst

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.914 Welcome to the Bristol-Myers Squibb Second Quarter 2026 Earnings Conference Call. 00:00:05.914 -- 00:00:09.036 All participants will be in a listen-only mode. 00:00:09.036 -- 00:00:12.738 Should you need assistance, please signal a conference specialist by pressing the star 00:00:12.738 -- 00:00:15.059 key followed by zero. 00:00:15.059 -- 00:00:20.182 After today's presentation, there will be an opportunity to ask questions. 00:00:20.182 -- 00:00:25.225 To ask a question, you may press star then one on your telephone keypad. 00:00:25.225 -- 00:00:29.947 To withdraw your question, please press star then two. 00:00:30.233 -- 00:00:32.233 I 00:00:32.417 -- 00:00:36.864 would now like to turn the conference over to Chuck Triano, Senior Vice President and 00:00:36.864 -- 00:00:41.369 Head of Investor Relations. Please go ahead. 00:00:42.053 -- 00:00:46.176 Thank you and good morning, everyone. We appreciate you joining our second quarter 2026 00:00:46.176 -- 00:00:50.659 earnings call. With me this morning with prepared remarks are Chris Boerner, our board 00:00:50.659 -- 00:00:55.322 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:55.322 -- 00:01:00.246 Also participating in today's call is Adam Lenkowski, our chief commercialization officer, 00:01:00.246 -- 00:01:05.377 and Cristian Massacesi, our chief medical officer and head of global drug development. 00:01:05.377 -- 00:01:09.901 Earlier this morning, we posted our quarterly slide presentation to BMS.com that you 00:01:09.901 -- 00:01:13.363 can use to follow along with Chris and David's remarks. 00:01:13.363 -- 00:01:17.246 Before we get started, I'll remind everybody that during this call, we will make statements 00:01:17.246 -- 00:01:22....